$TNIB NeWS$$- TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card
Last update: 28/07/2014 9:00:47 am
ORLANDO, Fla., July 28, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or the "Company"), a biopharmaceutical company focused on the development, marketing and distribution of opioid-related immunotherapies, announced today that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its 2014 Annual Meeting of Shareholders to be held on Thursday, September 4, 2014, at 10 a.m., East Standard Time. The record date for determining those shareholders eligible to receive notice of, and to vote at, the 2014 Annual Meeting was set as of July 15, 2014.
TNI BioTech strongly urges shareholders to vote, either by telephone, Internet or mail. Shareholders may also vote at the meeting, which will take place at the Citrus Club, 255 South Orange Avenue, Suite 1800, Orlando, FL 32801.
Commencing with the 2014 Annual Meeting, all directors standing for election would be elected to serve only until the following year's annual meeting.
All of TNI BioTech's new board nominees will qualify as independent directors under the NASDAQ listing rules. All Board committee memberships are restricted to independent directors.
SUPPORT TNI BIOTECH BY VOTING YOUR PROXY CARD TODAY
Your vote is important, no matter how many shares you own. Whether or not you plan to attend the Annual Meeting, we urge you to protect your investment in TNI BioTech by voting your shares via a toll-free telephone number or over the Internet. If you received a proxy card or voting instruction card by mail, you may submit your proxy card or voting instruction card by completing, signing, dating and mailing your proxy card or voting instruction card in the postage-paid envelope provided.
On behalf of your Board of Directors, we thank you for your continued support. We look forward to reporting our continued progress to you.
News 
Market Data 
Discover 
